Stay updated on Pembrolizumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added revision entry v3.5.3 to the revision history, replacing the prior v3.5.2 in the page's documentation record.
    Difference
    0.0%
    Check dated 2026-04-30T17:43:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Page revision note updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:14:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added the MeSH term Malignant lymphoma, large B-cell, diffuse to the study indexing terms.
    Difference
    0.0%
    Check dated 2026-04-02T01:33:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T17:56:51.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:25:12.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2; the earlier funding-status notice (Revision: v3.4.1) has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:20:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.